Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656578 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy
A Phase 3 study, sponsored by Anesiva.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00656578 is a Phase 3 study that has completed, run by Anesiva. The registered enrollment target is 300 participants.
The verdict
NCT00656578, a Phase 3 study, has completed, sponsored by Anesiva.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The primary purpose of this study is to compare the analgesic efficacy of a single intraoperative administration of 4975 vs. Placebo in the management of acute postoperative pain in patients undergoing bunionectomy. Secondary objective of this study is to evaluate the safety and tolerability of a single intraoperative administration of 4975.
Interventions
- DRUG Placebo
- DRUG 4975
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00656578
The ClinicalTrials.gov registry entry for NCT00656578 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anesiva, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00656578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00656578 about?
NCT00656578 is a clinical study titled "Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy". The primary purpose of this study is to compare the analgesic efficacy of a single intraoperative administration of 4975 vs. Placebo in the management of acute postoperative pain in patients undergoing bunionectomy. Secondary objective of this study is to evaluate the safety and tolerability of a s...
What is the current status of trial NCT00656578?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2008-03. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00656578?
The interventions under investigation include: Placebo (DRUG), 4975 (DRUG).
Who is sponsoring clinical trial NCT00656578?
This trial is sponsored by Anesiva, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.